2021-01-04,"b""Good job not promoting this contest more biotwit sphere.. If I could've I would've done something like $OMER $ACOR $PYBI on speculative 10x return with a thesis of forgotten biotech plays experiencing sales outperformance under Biden admin, return of pharma sales reps post COVID. https://t.co/mS5oZqp3XI"""
2021-01-03,"b'@MDollares @Benjami80128868 $OMER Narsoplimab IgAN phase 3 https://t.co/DfsZkR0758 Required reporting date Aug. 31, 2021, midnight, see Fdaaa tracker https://t.co/V0firUwV65 Can, if positive, during 2021 cause a major impact on $CALTX Nefecon'"
2021-01-03,b'2020-12-31 Short sale volume (not short interest) for $NOVN is 53%. https://t.co/36b9hfacoQ $ONTX 38% $OMER 47% $XLV 60%'
2021-01-03,b'$HLIX to bring to light new merger discussions already underway in Atlanta\nhttps://t.co/fK8PPZ6hwp\n\n$OMER $MCIG $ARYC $TRP $DUTV $CE $ETFM $IBKR $HOV $AOBC $BVN $RMRK'
2021-01-02,b'@MDollares @HoldStocks @Benjami80128868 Narsoplimab will be a gamechanger in kidney diseases in general. Lectin pathways plays a larger role than most people think. IgAN will a homerun when data is out. High proteinuria cohort likely this year. $omer #igan \nhttps://t.co/5fmQeLn9Or https://t.co/hMS7Joj6TG'
2021-01-02,b'@MDollares @Benjami80128868 $OMER Narsoplimab is better than $CALTX $CALT Nefecon. IgAN patients and now in phase 3. Primary Completion Aug 2020 https://t.co/7dyUF9r4YC Reduced proteinuria (phase 2) in IgA nephropathy patients by 50%-90%. https://t.co/EShx0wYm1C'
2021-01-02,"b'$OMER ""similar stricking results"" #FundingForNarsoplimabNow #TMA #endothelialinjury @EisThreat #Narsoplimab #masp2inhibition #complement https://t.co/7d0roi3E5s'"
2021-01-02,"b'RT @WallStChameleon: Huge CMS decision for $OMER now fading after the monster 25% initial pop. Omeros: ""Omirida added to ophthalmic irrigat\xe2\x80\xa6'"
2021-01-02,"b'Huge CMS decision for $OMER now fading after the monster 25% initial pop. Omeros: ""Omirida added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement"" is its only approved drug. Passthrough reimbursement has been open question since 2018.'"
2021-01-01,b'$OMER in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/eN2QcImfYx #Omeros #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/B7OjFKiqF2'
2021-01-01,b'#TMA in all kids with #COVID19 severe or not!! Make #Narsoplimab available ASAP! @EisThreat $OMER https://t.co/VWTxqv0CBU'
2021-01-01,b'$OMER Need a bullish start to 2021? Listen to Q3. 2021 gonna be a paradigm changing year for the company and stockprice AND Omeros have all the money in the world to make it happen. CEO speaks the truth. Tamed CMS #omidria #separa... https://t.co/POFaItFl3Y'
2021-01-01,"b'TD BUY $OMER at 14.29, Supp 14.29 Resis 15.19 R6  HiLo 34% T1Y 33 buy 2.2 fwdPE -8.2 DIV N/A #Omeros Cor #stocks #trading #finance #market https://t.co/4qLapszthC https://t.co/r8z8Jfgprr'"
2021-01-01,b'$OMER was analyzed by 5 analysts. The buy consensus is at 92%. So analysts seem to be very confident about $OMER. https://t.co/tetljxsGTO https://t.co/xKdkmrqKXn'
2021-01-01,b'RT @CarlosALacasa: @Benzinga $OMER'
2021-01-01,b'@Benzinga $OMER'
2020-12-31,b'$OMER in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/dFeYwxKVgB #Omeros #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nF8qWs6ZVC'
2020-12-31,b'RT @SeekingAlpha: $OMER - Omeros: A Ripening Fruit Ready To Pick. https://t.co/3biJQ9OZAW #economy #trading #markets'
2020-12-31,b'Short sale volume (not short interest) for $MTNB on 2020-12-30 is 52%. https://t.co/d5W3fnHLhJ $XLV 71% $ONTX 57% $OMER 47%'
2020-12-30,b'RT @_joebaffoe: $OMER Number 1 performing Biotech for 2021! Book it Danno!'
2020-12-30,b'$OMER Number 1 performing Biotech for 2021! Book it Danno!'
2020-12-30,b'RT @_joebaffoe: $OMER Presence of Protein in Urine: A Potential Tool in IgAN Clinical Trials https://t.co/Ce5c0cakLV This data supports the\xe2\x80\xa6'
2020-12-30,b'$OMER Presence of Protein in Urine: A Potential Tool in IgAN Clinical Trials https://t.co/Ce5c0cakLV This data supports the use of proteinuria reduction as a surrogate endpoint. 2021 is going to be a BREAKOUT year for Omeros. Narsoplimab = BLOCKBUSTER DRUG'
2020-12-30,b'2020-12-29 Short sale volume (not short interest) for $CHMA is 49%. https://t.co/qlHVZ3s0lj $XLV 55% $OMER 54% $ONTX 54%'
2020-12-30,b'RT @Varuncharger: @Pharmdca $omer'
2020-12-30,b'@Pharmdca $omer'
2020-12-29,b'@OphirGottlieb Finally $OMER!!'
2020-12-29,b'$OMER Phase 2 trial w/est Dec completion date NCT02682407: https://t.co/Xn4Ykqv4VC Trial Tracker: https://t.co/aR7q5oJwjn'
2020-12-29,b'Short sale volume(not short interest) for $MTNB on 2020-12-28 is 54%. https://t.co/d5W3fnHLhJ $OMER 49% $XLV 74% $ONTX 58%'
2020-12-28,b'Short sale vol (not short interest) for $ACST on 2020-12-24 is 41%. https://t.co/m3OKhv4zvv $ONTX 55% $XLV 56% $OMER 36%'
2020-12-28,b'Short sale vol (not short interest) for $NOVN on 2020-12-24 is 51%. https://t.co/36b9hfacoQ $ONTX 55% $OMER 36% $XLV 56%'
2020-12-28,"b'@_joebaffoe Cool! So beside being responsible for most common glomerulonephritis #igan, Lectin-Pathway is also likely responsible for the most commen cause of nephrotic syndrome #pMN. 30% of pMN devolves ESRD. $OMER'"
2020-12-28,"b'$OMER Trimmed some of my lowest cost basis shares from the March dip today. Nothing major, less than 10% of current position.'"
2020-12-28,b'$OMER another nice flag pattern here. Surely breaks to the upside. Could risk off $14.50 ish level'
2020-12-28,b'$OMER https://t.co/PWxBtK7pZP\n1) Our findings have important therapeutic implications. Current treatments of pMN consist of\ninitial non-immunosuppressive therapy with ACE-inhibitors or angiotensin receptor blockers\nand immunosuppressive treatments in the case of severe disease or'
2020-12-28,b'@semodough I felt the same way about $HALO for years. Oh...and still do about $OMER!'
2020-12-28,b'2020-12-24 Short sale volume (not short interest) for $MTNB is 52%. https://t.co/d5W3fnHLhJ $ONTX 55% $XLV 56% $OMER 36%'
2020-12-28,b'2020-12-24 Short sale volume (not short interest) for $MTNB is 52%. https://t.co/d5W3fnHLhJ $XLV 56% $OMER 36% $ONTX 55%'
2020-12-28,b'2020-12-24 Short sale volume (not short interest) for $ACST is 41%. https://t.co/m3OKhv4zvv $OMER 36% $ONTX 55% $XLV 56%'
2020-12-27,b'(PDF) Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art $omer https://t.co/LovxjAf66F'
2021-01-08,"b""New for our readers - a quick daily tech chart. $IBB $XBI Off our trading list - $OMER Recently had a 'breakaway gap'.  + $SPY tech charts daily. Follow us or others on a social site for traders - Join &amp; make your own comments/ask questions &gt; https://t.co/Jw4j70yUkZ"""
2021-01-08,b'$OMER in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/lz855Pb2vk #Omeros #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MEjyl0wtoU'
2021-01-07,b'$OMER 1) Our work in TA-TMA and other endothelial injury syndromes allowed us in collaboration with Professor Alessandro Rambaldi to recognize the pathophysiologic similarities between TA-TMA and COVID-19. Both our endothelial injury syndromes and involved as an early and central'
2021-01-07,"b""$OMER if they announce another 100 CU Covid patients, they treated 6 in one week in March. Now it's offered in the US under CU as well. Add funding by CMS, the stock would open in the $30's"""
2021-01-07,b'RT @SnackBioTech: $XAIR $HZNP $ONCT trimming quite a bit. Leaving shares to help me keep track because I like them long term potentially. $\xe2\x80\xa6'
2021-01-07,"b'$XAIR $HZNP $ONCT trimming quite a bit. Leaving shares to help me keep track because I like them long term potentially. $BTAI $FGEN my laggards. $OMER thinking about running away, but the volume isn\xe2\x80\x99t quite there. Not sure what to make of it. Wouldn\xe2\x80\x99t be shocked by a pullback https://t.co/2xM5dtNgOE'"
2021-01-07,"b""$OMER right now there's a game of JENGA going on with Omeros stock. So far about 15 blocks have been pulled, when they pull the Covid/funding block the entire stack come tumbling down with all the shorts running for the hills!"""
2021-01-07,b'RT @DayTradeWarrior: LIVE Day Trading Watch List for MONDAY 8/10/2020 $MCRB $HOTH $OMER $IBIO https://t.co/y1dwSk2hcF'
2021-01-07,b'Rose Above Upper Bollinger Band today: $OCX $OMER $HMN $BCC $RLGY $MTOR $AXL $DKL $CYRX $NAK $XLI $NBY $TOPS $ALSN $RRR $RIG $FTXL $LPX $CHIX $WEX ... https://t.co/AyIukUGmib'
2021-01-07,"b'Those cash secured puts on $INO, $OMER and $NNDM are doing very well. They expire in February https://t.co/3FZJ5q0pIr'"
2021-01-07,"b'Updated January positions:\n\n$CVS $OMER $PAVM $TDOC $TAP $RKT $PHIO $MAXR $ONCT $KR $INTC $GIGM $DKNG $BTAI $AUPH $LPTX $ABUS $REI $SIOX \n\nSavings account of All the #Silver and #Gold ETFs, bullion and #bitcoin'"
2021-01-06,"b'$OMER 1) Narsoplimab treatment was associated with rapid and sustained reduction of CEC and concurrent reduction of serum IL-6, IL-8, CRP and LDH. Narsoplimab was well tolerated; no adverse drug reactions were reported.https://t.co/lkYsj5pWRg'"
2021-01-06,b'RT @LadyJustice6910: Good instincts and knowing how and what will affect the market is what determines success and failure. I liquidated al\xe2\x80\xa6'
2021-01-06,"b'$OMER A breakthrough drug saved the lives of every critical coronavirus patient who took it ""This is where narsoplimab may come to the rescue it\xe2\x80\x99s not supposed to block the coronavirus from infecting cells like other monoclonal therapies being tested"" \nhttps://t.co/8PIWOWpdiN'"
2021-01-06,b'RT @LadyJustice6910: Good instincts and knowing how and what will affect the market is what determines success and failure. I liquidated al\xe2\x80\xa6'
2021-01-06,"b""Good instincts and knowing how and what will affect the market is what determines success and failure. I liquidated almost everything the other day, because I knew this was going to happen. One I kept was $OMER. This is what success and knowing what you're doing looks like. https://t.co/3jfxaKJrHk"""
